| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 06/15/2011 | CN1865275B Artificial single-chain deoxynucleotide having therapeutic effect to human B cell tumour |
| 06/15/2011 | CN1849135B Methods for treating interleukin-6-related diseases |
| 06/15/2011 | CN1847256B Antiviral prepn containing both CpG single-strand deoxyoligonucleotide and ribavirin |
| 06/15/2011 | CN1832948B 1- alkyl-1-azoniabicyclo (2.2.2) octane carbamate derivatives and their use as muscarinic receptor antagonists |
| 06/15/2011 | CN1830964B 4-Substituting anilino-3-nitroquinoline compounds, prepn. method and use thereof |
| 06/15/2011 | CN1820734B Treatment with anti-erbb2 antibodies |
| 06/15/2011 | CN1700923B Multi-substituted selective androgen receptor modulators and methods of use thereof |
| 06/15/2011 | CN102099687A Compositions and methods of treatment using modulators of motoneuron diseases |
| 06/15/2011 | CN102099474A Oligonucleotides for treating inflammation and neoplastic cell proliferation |
| 06/15/2011 | CN102099471A Aptamer against il-17 and use thereof |
| 06/15/2011 | CN102099467A SiRNA of human osteopontin |
| 06/15/2011 | CN102099397A A method of synthesizing a substantially monodispersed mixture of oligomers |
| 06/15/2011 | CN102099377A CD37 immunotherapeutic and combination with bifunctional chemotherapeutic thereof |
| 06/15/2011 | CN102099368A C-21 thioethers as glucocorticoid receptor agonists |
| 06/15/2011 | CN102099367A Nucleoside and nucleotide analogues with quaternary carbon centers and methods of use |
| 06/15/2011 | CN102099362A Selenophene and selenazole carboxylic acid derivatives |
| 06/15/2011 | CN102099360A Hydroxy substituted thieno pyrimidinones as melanin concentrating hormone receptor-1 antagonists |
| 06/15/2011 | CN102099359A Hepatitis c virus inhibitors |
| 06/15/2011 | CN102099358A Compound with serotoninergic activity, process for preparing same and pharmaceutical composition comprising same |
| 06/15/2011 | CN102099357A Carboxamide compounds for the treatment of metabolic disorders |
| 06/15/2011 | CN102099356A Heterocyclic derivatives as modulators of ion channels |
| 06/15/2011 | CN102099355A Phenyl and benzodioxinyl substituted indazoles derivatives |
| 06/15/2011 | CN102099354A Azole compound |
| 06/15/2011 | CN102099353A Hepatitis c virus inhibitors |
| 06/15/2011 | CN102099352A STAT3 inhibitor containing quinolinecarboxamide derivative as active ingredient |
| 06/15/2011 | CN102099351A 3-heterocyclic substituted indole derivatives and methods of use thereof |
| 06/15/2011 | CN102099344A Imidazole carboxamides |
| 06/15/2011 | CN102099342A Aminotetrahydroindazoloacetic acids |
| 06/15/2011 | CN102099341A Aminotetrahydroindazoloacetic acids |
| 06/15/2011 | CN102099340A Heterocyclic compounds as factor IXA inhibitors |
| 06/15/2011 | CN102099339A Benzazepine derivatives and their use as hstamine h3 antagonists |
| 06/15/2011 | CN102099338A Heterocyclic derivatives that are used in the treatment of neurodegenerative diseases |
| 06/15/2011 | CN102099337A Piperazine derivatives used as cav2.2 calcium channel modulators |
| 06/15/2011 | CN102099336A Novel phenylamino isonicotinamide compounds |
| 06/15/2011 | CN102099335A Heterocyclic antiviral compounds |
| 06/15/2011 | CN102099334A Novel compounds active as muscarinic receptor antagonists |
| 06/15/2011 | CN102099333A 6-substituted indole-3-carboxylic acid amide compounds having sphingosine-1-phosphate (s1p) receptor antagonist biological activity |
| 06/15/2011 | CN102099330A Nitric oxide donating prostamides |
| 06/15/2011 | CN102099056A A pharmaceutical composition |
| 06/15/2011 | CN102099047A Composition for controlling increase in blood glucose |
| 06/15/2011 | CN102099042A Mono ( iron hydroxypyrone ) and combination ( iron hydroxypyrone and gi inflammation inhibiting agents ) compositions for anaemia or h. pylori infections |
| 06/15/2011 | CN102099041A Antisense formulation |
| 06/15/2011 | CN102099040A Pregesteron antagonists such as cdb-4124 in the treatment of breast cancer |
| 06/15/2011 | CN102099039A Use of pyrimidylaminobenzamide derivatives for the treatment of fibrosis |
| 06/15/2011 | CN102099038A Materials and methods for suppressing and/or treating neurofibroma and related tumors |
| 06/15/2011 | CN102099037A Stable aqueous solution composition containing sulfonamide compound |
| 06/15/2011 | CN102099036A Compounds and methods for treating inflammatory and fibrotic disorders |
| 06/15/2011 | CN102099035A Immunomodulation by IAP inhibitors |
| 06/15/2011 | CN102099034A Antineoplastic combinations containing HKI-272 and vinorelbine |
| 06/15/2011 | CN102099033A Pharmaceutical composition for treatment of fibromyalgia |
| 06/15/2011 | CN102099032A Methods of treating alpha adrenergic mediated conditions |
| 06/15/2011 | CN102099031A Substituted indolyl and indazolyl derivatives and uses thereof |
| 06/15/2011 | CN102099030A Methods and compositions for the treatment or prevention of pathological cardiac remodeling and heart failure |
| 06/15/2011 | CN102099029A Formulations for treating eye disorders |
| 06/15/2011 | CN102099028A A novel standardized composition, method of manufacture and use in the resolution of rna virus infection |
| 06/15/2011 | CN102099027A Fulvic acid and antibiotic combination |
| 06/15/2011 | CN102099026A Therapeutic compositions containing macitentan |
| 06/15/2011 | CN102099025A Combination therapy with an antitumor alkaloid |
| 06/15/2011 | CN102099024A Use of nitrated lipids for treatment of side effects of toxic medical therapies |
| 06/15/2011 | CN102099023A Agent for activating stem cells |
| 06/15/2011 | CN102099022A Anhydrous depigmenting compositions comprising, within the fatty phase, a solubilized phenolic derivative and a retinoid |
| 06/15/2011 | CN102099021A Use of hdac inhibitors for the treatment of hodgkin's disease |
| 06/15/2011 | CN102099018A Oral formulations of cytidine analogs and methods of use thereof |
| 06/15/2011 | CN102099017A High content sodium ibuprofen granules, their preparation and their use in preparing non-effervescent solid dosage forms |
| 06/15/2011 | CN102099016A Drug loaded polymeric nanoparticles and methods of making and using same |
| 06/15/2011 | CN102099012A Method for manufacturing medicinal compounds containing dabigatran |
| 06/15/2011 | CN102099009A Pulmonary delivery of a fluoroquinolone |
| 06/15/2011 | CN102099001A Series of skin-whitening (lightening) compounds |
| 06/15/2011 | CN102098929A Composition of soluble indigestible fibre and of eukaryotic organisms with a polysaccharide wall, used in the well-being field |
| 06/15/2011 | CN102098918A Bioactive compounds for treatment of cancer and neurodegenerative diseases |
| 06/15/2011 | CN102098917A Substituted pyridazine carboxamide compounds as kinase inhibitor compounds |
| 06/15/2011 | CN102098914A Novel compositions and methods for treating hyperproliferative diseases |
| 06/15/2011 | CN102093462A Preparation method and application of 1alpha, 2alpha-dyhydroxyl oleanolic acid |
| 06/15/2011 | CN102093460A Triterpenoid saponin compound as well as synthesis method and application of triterpenoid saponin |
| 06/15/2011 | CN102093459A Penthorum chinense pursh extract and preparation method and application thereof |
| 06/15/2011 | CN102093452A Hydrogenation type ginsenoside aglycons as well as preparation method and application of hydrogenation type ginsenoside aglycons |
| 06/15/2011 | CN102093448A Particulate composition containing anhydrous crystalline 2-O-alpha -D-glucosyl-L-ascorbic acid, process for producing the same, and uses thereof |
| 06/15/2011 | CN102093424A Platinum coordination compound of anti-tumor medicaments |
| 06/15/2011 | CN102093422A Acyclic nucleoside phosphonate derivative and medicinal application thereof |
| 06/15/2011 | CN102093421A Phosphorus substituent group-containing quinoline compound and preparation method of quinoline compound as well as pharmaceutical composition containing quinoline compound and application of pharmaceutical composition |
| 06/15/2011 | CN102093411A Lysine-based compounds |
| 06/15/2011 | CN102093389A Duplex and oxygen bridge heterlcyclic ring anabasine compound and preparation method thereof |
| 06/15/2011 | CN102093387A Crystal compound of 4,5,6,7-tetrahydro-isoxazolo[5,4-c]pyridine-3-alcohol-hydrate |
| 06/15/2011 | CN102093385A Schiff base compounds as well as preparation method and application of Schiff base compounds |
| 06/15/2011 | CN102093380A Cyclic icaritin aglycon as well as preparation method and application of cyclic icaritin aglycon |
| 06/15/2011 | CN102093376A Furocoumarin compound and application thereof |
| 06/15/2011 | CN102093373A Compounds formed by structural modifiecation of sinomenine and preparation method thereof |
| 06/15/2011 | CN102093366A Bicyclo-amino pyrazol compound and application of bicycle-amino pyrazol compound in resisting coxsackie virus |
| 06/15/2011 | CN102093364A 2,4-diamido-6,7-dihydro-5H-pyrrolo [2,3] pyrimidine derivative as focal adhesion kinase/pyruvate kinase 2 (FAK/Pyk2) inhibitor |
| 06/15/2011 | CN102093363A Pyrrolo-triazine aniline compounds useful as kinase inhibitors |
| 06/15/2011 | CN102093360A Process for preparing a dihydropteridinone derivative |
| 06/15/2011 | CN102093358A Brominated indolizinoquinoline dione derivative and application of brominated indolizinequinoline dione derivative in preparing antibiotic medicament |
| 06/15/2011 | CN102093357A Novel indoletriazole alkaloid as well as preparation method and antifungal application thereof |
| 06/15/2011 | CN102093353A 7-substituted aza-indazoles, compositions containing same, production method and use thereof |
| 06/15/2011 | CN102093347A 1,3,6-trisubstituted-beta-carboline cyclin-dependent kinase 2 inhibitor and application thereof |
| 06/15/2011 | CN102093341A Indole ring substituted pyrazole carboxylic acid endothelin receptor antagonist as well as preparation method and application thereof |
| 06/15/2011 | CN102093340A Preparation method and application of 2-methylindazole derivatives |
| 06/15/2011 | CN102093339A Preparation method and application of pyrimidine derivatives |
| 06/15/2011 | CN102093332A Lignan compound and preparation method thereof |
| 06/15/2011 | CN102093331A Chiral 2-amino-pyran compounds and preparation method and antibacterial application thereof |